Persons infected with human immunodeficiency Virus (HIV) developed a severe form of transmissible immune deficiency. The immune defect results in opportunistic infecitons and malignancies. There are over 750,000 Americans with HIV infection and death from HIV infection occurs in greater that 95 percent of HIV infected individuals. Current treatments select for viral resistance which limits the clinical efficacy of current drugs. As yet, there is no therapeutic intervention which results in the elimination of infection by HIV. Consequently, there is not cure for HIV infection. Prevention of infection remains a major public health aim. Intervention efforts which would afford an increased level of safety for persons engaging sexual intercourse with high-risk individuals could substantially decrease the rate of new transmissions of HIV in the United States. Protegrins are a unique, new class of small peptide antibiotics with antiretroviral activity. They are stable to proteolytic cleavage and chemical denaturation, poorly immunogenic, and rapidly taken up by target cells. At 5 mug/mL, natural and synthetic protegrin completely inhibited de novo HIV infection with a primary clinical isolate (JR-CSF) in human peripheral blood lymphoblast cultures. Similar effects were seen in monocyte cultures using JR-FL. Protegrins inhibited infection if added before inoculation and up to two hours later. No effects were seen if added after 24 hours. There are significant structure/activity features as truncated versions of protegrins and related peptide antibiotics either had reduced or no effect. This application proposes to significantly expand our understanding of the biology of protegrins as anti-HIV prophylactic and therapeutic agents. We will evaluate a series of protegrin derivatives in order to optimize the activity of these agents. We will survey their activity against other retroviruses and will delineate the nature of the structure/activity relationships. Finally, we will identify the site in HIV replication where protegrins act and develop high volume screening assays to be used to identify newer and more active derivative peptides and peptidomimetics. The ultimate goal is to develop protegrins as a preventative agent for the transmission of HIV when used during intercourse and as a potential therapeutic agent for those already infected with HIV.

Project Start
1998-03-01
Project End
1999-09-29
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Gryllos, Ioannis; Tran-Winkler, Hien J; Cheng, Ming-Fang et al. (2008) Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sci U S A 105:16755-60
Doherty, Tim; Waring, Alan J; Hong, Mei (2008) Dynamic structure of disulfide-removed linear analogs of tachyplesin-I in the lipid bilayer from solid-state NMR. Biochemistry 47:1105-16
Tang, Ming; Waring, Alan J; Hong, Mei (2007) Phosphate-mediated arginine insertion into lipid membranes and pore formation by a cationic membrane peptide from solid-state NMR. J Am Chem Soc 129:11438-46
Mani, Rajeswari; Waring, Alan J; Hong, Mei (2007) Conformation, dynamics, and insertion of a noncysteine-containing protegrin-1 analogue in lipid membranes from solid-state NMR spectroscopy. Chembiochem 8:1877-84
Doherty, Timothy; Waring, Alan J; Hong, Mei (2006) Peptide-lipid interactions of the beta-hairpin antimicrobial peptide tachyplesin and its linear derivatives from solid-state NMR. Biochim Biophys Acta 1758:1285-91
Mani, R; Tang, M; Wu, X et al. (2006) Membrane-bound dimer structure of a beta-hairpin antimicrobial peptide from rotational-echo double-resonance solid-state NMR. Biochemistry 45:8341-9
Tang, Ming; Waring, Alan J; Lehrer, Robert I et al. (2006) Orientation of a beta-hairpin antimicrobial peptide in lipid bilayers from two-dimensional dipolar chemical-shift correlation NMR. Biophys J 90:3616-24
Cole, Amy L; Yang, Otto O; Warren, Andrew D et al. (2006) HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41. J Immunol 176:6900-5
Doherty, Tim; Waring, Alan J; Hong, M (2006) Membrane-bound conformation and topology of the antimicrobial peptide tachyplesin I by solid-state NMR. Biochemistry 45:13323-30
Mani, Rajeswari; Cady, Sarah D; Tang, Ming et al. (2006) Membrane-dependent oligomeric structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR. Proc Natl Acad Sci U S A 103:16242-7

Showing the most recent 10 out of 62 publications